Publications by authors named "Jane Fang"

Claim this Profile
C
Contact Sensitization and Phototoxic and Photoallergic Potential of Tirbanibulin 1% Ointment in Healthy Volunteers.
Jonathan Dosik, David L Cutler, Jane Fang, Laura Padullés

JID Innov· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results.
Jin-Bon Hong, Po-Yuan Wu, Albert Qin, Yi-Wen Huang, Kuan-Chiao Tseng, Jane Fang, Tsen-Fang Tsai

Pharmaceutics· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel long-acting ropeginterferon alfa-2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial.
Yi-Wen Huang, Albert Qin, Jane Fang, Ting-Fang Wang, Chung-Wei Tsai

Br J Clin Pharmacol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects With Actinic Keratosis.
Regina Yavel, J Scott Overcash, David Cutler, Jane Fang, Jay Zhi

Clin Pharmacol Drug Dev· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.
Andrew Blauvelt, Steven Kempers, Edward Lain, Todd Schlesinger, Stephen Tyring, Jane Fang

N Engl J Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results.
Steven Kempers, Janet DuBois, Seth Forman, Amy Poon, Eva Cutler, Jane Fang

J Drugs Dermatol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361).
Michael P Smolinski, Yahao Bu, James Clements, Irwin H Gelman, Taher Hegab, Jane W S Fang

J Med Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic expression of cell proliferation markers and growth factors in giant cell hepatitis: implications for the pathogenetic mechanisms involved.
Jane W S Fang, Regino P González-Peralta, Sonny K F Chong, Grace M Lau, Gillian M Lau

J Pediatr Gastroenterol Nutr· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro.
Grace M Lau, Gillian M Lau, Guo-Liang Yu, Irwin H Gelman, Alan Gutowski, Jane W S Fang

Dig Dis Sci· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexisting tricuspid valve dysplasia and ventricular septal defect in a young patas monkey (Erythrocebus patas).
Liang Sao-Ling, Yu Jane-Fang, Cheng Chian-Ren, Chin Shih-Chien

J Zoo Wildl Med· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In situ detection of hepatitis B viral antigens.
Jane W S Fang, Johnson Y N Lau

Methods Mol Med· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis